Citation Impact
Citing Papers
Circadian oscillation of nucleotide excision repair in mammalian brain
2009 StandoutNobel
The evolution of image reconstruction for CT—from filtered back projection to artificial intelligence
2018
Calicheamicin-conjugated humanized anti-CD33 monoclonal antibody (gemtuzumab zogamicin, CMA-676) shows cytocidal effect on CD33-positive leukemia cell lines, but is inactive on P-glycoprotein-expressing sublines
2000
Photodynamic Therapy
1998 Standout
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non–small‐cell lung cancer patients
2012
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Cancer Statistics, 2006
2006 Standout
Mismatch repair and nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks
2009 StandoutNobel
Plasminogen activation at the cell surface-matrix interface
1990
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer
2013 Standout
Imaging Studies in Metastatic Urogenital Cancer Patients Undergoing Systemic Therapy: Recommendations of a Multidisciplinary Consensus Meeting of the Association of Urological Oncology of the German Cancer Society
2010
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Preparing Medical Imaging Data for Machine Learning
2020 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers
2002
Cisplatin: The first metal based anticancer drug
2019 Standout
Distribution of tetrapyrrole photosensitizers among human plasma proteins
1992
Repair of DNA interstrand cross-links
2001
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration
2008
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
The role of lipoproteins in the delivery of tumour-targeting photosensitizers
1993
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
2011
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Antitumor Antibiotics: Bleomycin, Enediynes, and Mitomycin
2005 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin.
1993
Factors Affecting the Risk of Brain Metastases After Definitive Chemoradiation for Locally Advanced Non–Small-Cell Lung Carcinoma
2001
Geologically current motion of 56 plates relative to the no-net-rotation reference frame
2011 Standout
Asymmetric Catalysis by Architectural and Functional Molecular Engineering: Practical Chemo- and Stereoselective Hydrogenation of Ketones
2001 StandoutNobel
Basic principles of photodynamic therapy
2001 Standout
The Terceira Rift as hyper-slow, hotspot-dominated oblique spreading axis: A comparison with other slow-spreading plate boundaries
2003
Global continental and ocean basin reconstructions since 200Ma
2012 Standout
Asymmetrische Katalyse mit hinsichtlich Struktur und Funktion gezielt entworfenen Molekülen: die chemo- und stereoselektive Hydrierung von Ketonen
2001 StandoutNobel
Matrix Metalloproteinases: A Review
1993 Standout
Geologically current plate motions
2010 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Phase I and pharmacokinetic study of ormaplatin (tetraplatin, NSC 363812) administered on a day 1 and day 8 schedule.
1994
Works of Mark Müller being referenced
Grating-based X-ray Dark-field Computed Tomography of Living Mice
2015
Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer
2007
Improved flow‐cytometric detection of low P‐glycoprotein expression in leukaemic blasts by histogram subtraction analysis
1994
Differential modulation of chemosensitivity to alkylating agents and platinum compounds by DNA repair modulators in human lung cancer cell lines
2000
Differential properties of cisplatin and tetraplatin with respect to cytotoxicity and perturbation of cellular glutathione levels
1991
Elevated apolipoprotein(A) levels in cancer patients
1989
Mid-Atlantic Ridge–Azores hotspot interactions: along-axis migration of a hotspot-derived event of enhanced magmatism 10 to 4 Ma ago
1999
Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer
2006
249 Preoperative chemotherapy and concurrent chemoradiotherapy based on hyperfractionated accelerated radiation followed by surgery in locally advanced (LAD) inoperable NSCLC stages IIIA and IIIB — The value of PCI
1997